Safety, Tolerability, and PK of Escalating Doses of Flufirvitide-3 Dry Powder for Inhalation in Healthy Subjects

NCT01990846 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

68

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

DRUG: Flufirvitide 3
DRUG: Placebo for Flufirvitide-3

Sponsor

Autoimmune Technologies, LLC